TRACY SOKOLOSKI: Open Payments
NPI 1942632898 · SCRANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,502 in 100 payments from 12 companies in 2025. Trend: 2023 $1,008 · 2024 $1,194 · 2025 $1,502
Food & beverage: $1,502
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $458 |
| Amgen Inc. | 14 | $198 |
| UCB, Inc. | 8 | $180 |
| AstraZeneca Pharmaceuticals LP | 7 | $165 |
| Novartis Pharmaceuticals Corporation | 12 | $163 |
| GlaxoSmithKline, LLC. | 5 | $143 |
| Organon LLC | 2 | $56 |
| Genentech USA, Inc. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Janssen Biotech, Inc. | 1 | $31 |
Products named: RINVOQ, Bimzelx, SAPHNELO, COSENTYX, BENLYSTA, SKYRIZI, HADLIMA, KRYSTEXXA.
Industry payments across PA — which companies pay providers there.
